510(k) Report

510(k) · Cleared

Cleared

iStent infinite Trabecular Micro-Bypass System, Model iS3

K220032510(k) TraditionalCleared Aug 2, 2022209-day reviewClass II21 CFR 886.3920

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Glaukos Corporation · KYF Implant, Eye Valve

Cleared on Aug 2, 2022 as substantially equivalent to K161457 (Allergan, Inc., 2016) after a 209-day review. Its family tree reaches back 5 generations to 1988.

Decided
Aug 2, 2022
Review
209 days
Class
Class II
Product code
KYF
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K875099 (1988). 8 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 5 generations backK875099 Molteno Valve SetonStaar Surgical Co. · 1988
  2. 4 generations backK925636 Ahmed Glaucoma Valve ImplantNew World Medical, Inc. · 1993
  3. 3 generations backK980657 Ahmed Glaucoma Valve, Model S3New World Medical, Inc. · 1998
  4. 2 generations backK012852 EX-Press Minature Glaucoma Implant, Models R-20, R-30, R-50, STS…Optonol, Ltd. · 2002
  5. 1 generation backK161457 XEN Glaucoma Treatment SystemAllergan, Inc. · 2016 · Recalled
  6. This deviceK220032 iStent infinite Trabecular Micro-Bypass System, Model iS3Glaukos Corporation · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K875099Molteno Valve SetonStaar Surgical Co.1988—
−4K925636Ahmed Glaucoma Valve ImplantNew World Medical, Inc.1993—
−3K980657Ahmed Glaucoma Valve, Model S3New World Medical, Inc.1998—
−2K012852EX-Press Minature Glaucoma Implant, Models R-20, R-30, R-50, STS VersionsOptonol, Ltd.2002—
−1K161457XEN Glaucoma Treatment SystemAllergan, Inc.20161
0 (this device)K220032iStent infinite Trabecular Micro-Bypass System, Model iS3Glaukos Corporation2022—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
199110
199710
FIG. 1 — Lineage of K220032, 1988–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KYF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KYF device

  1. #1 K231051 Ahmed® Glaucoma Valve Model FP8score 6.2 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K161457XEN Glaucoma Treatment System
Summary page 4
…Class II (special controls) Device Product Code: KYF (“Implant, Eye Valve”) III. PREDICATE DEVICE • XEN Glaucoma Treatment System (K161457), 21 CFR 886.3920, Product Code KYF IV. DEVICE DESCRIPTION The iStent infinite Trabecular Micro-Bypass System Model iS3…
Allergan, Inc.20161

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 34 years and passes through 5 companies; a new generation was cleared every 5.6 years on median.
  • 1 of the 8 ancestors has a recall of any class.

How does its category compare?

All KYF devices

KYF Implant, Eye Valve: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · KYF

2in 2023

2015: 12016: 22017: 12019: 12022: 12023: 2
2007high 2 (2016) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KYF

Too few KYF 510(k)s in any year since 2007 to give a median.

Recalls per year · KYF

1in 2019

2019: 1
2007high 1 (2019) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KYF

268in 2025

2007: 52008: 22009: 42010: 392011: 382012: 1162013: 1452014: 2882015: 2052016: 1982017: 2682018: 2582019: 5162020: 4372021: 4122022: 2992023: 3142024: 3122025: 268
2007high 516 (2019) · low 2 (2008)2025

MAUDE reports naming product code KYF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—05
20080—02
20090—04
20100—039
20110—038
20120—0116
20130—0145
20140—0288
20151—0205
20162—0198
20171—0268
20180—0258
20191—1516
20200—0437
20210—0412
20221—0299
20232—0314
20240—0312
20250—0268
20260—0—

What is it indicated for?

The iStent infinite® Trabecular Micro-Bypass System Model iS3 an implantable device intended to reduce the intraocular pressure (IOP) of the eye. It is indicated for use in adult patients with primary open-angle glaucoma in whom previous medical and surgical treatment has failed.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K220032: iStent infinite Trabecular Micro-Bypass System, Model iS3.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K220032

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026